LG
LGND
Market ClosedLigand Pharmaceuticals Incorporated
US
47 employees
CEO: Todd C. Davis
Founded: 1992
$300.95
+$0.00(+NaN%)
Market Cap
6.03B
Beta
0.98
52W Range
N/A
Dividend Yield
0.15%
LGND Price Chart
Historical price performance
Loading MCI price data...
MarketCI Investment Signals
AI-synthesized investment signal for LGND built from valuation, fundamentals, sentiment, and risk models
Investment Signal
BuyPass %
71.43%
Score
5/7
Fair Value Estimate
Cash flow analysis • Multiple methods
$43.73
AI Price Target
Machine learning • Price prediction
$427.22
Market Sentiment
News & social media analysis
0.00
Value Investor Price
Classic value analysis
$0.00
Financial Health
Bankruptcy risk assessment
7.49
Quality Score
Financial strength rating
6.00
AI Investment Grade
Deep analysis of filings & news
75.00
Key Investment Highlights
Important factors affecting LGND investment thesis
Due Diligence Analysis
Investment criteria assessment and scoring
Overall Assessment
71.05% Good
Conditions Met
27.00/38.00
Due Diligence Score
71.05%Due Diligence Conditions
Investment analysis conditions and results
Pass | |
Fail | |
Pass | |
Pass | |
Pass | |
Pass |
Showing 1 to 6 of 46 conditions
Latest News
Recent news and updates for LGND
No recent news available for LGND
Core Financials
Loading financial data for LGND...
Explore LGND
LGND in the Healthcare
Mid Cap